A staggering 93% of chemical companies claim freight transportation and supply chain disruptions have affected them negatively.

The FDA has long been criticized for lapses in inspections of overseas manufacturing in China and India, which are the two major producers of drugs and raw ingredients for medicines.

The deal would bolster Sartorius’s portfolio of drug-delivery technologies, creating a deeper focus on the fast-growing field of viral vectors, which are tools used to deliver genetic material into cells.

A ransomware group has claimed responsibility for the incident, which included a breach of some file systems and theft of certain company and personal data.

Pfizer has been under pressure to show it can capitalize on its COVID-19 windfall, after vaccine revenue almost doubled its sales in a single year.

While Ozempic is sold across Europe, Wegovy is yet to launch in most of the region and has also faced shortages in the U.S.  

What lessons did the healthcare supply chain learn from the COVID-19 pandemic? 

A little-known federal agency in charge of stockpiling vaccines and mobilizing supplies in health emergencies is being reorganized to apply lessons learned in the Covid pandemic.

Biogen Inc.’s new chief executive officer outlined some of his first steps toward his vision for the biotechnology company with plans to boost investment in new drugs the company is developing for Alzheimer’s disease, lupus and other illnesses.

Through its savvy but legal exploitation of the U.S. patent system, Humira’s manufacturer, AbbVie, was able to block competitors from entering the market.